Free Trial

Sutro Biopharma (STRO) Short Interest Ratio & Short Volume

Sutro Biopharma logo
$0.84 +0.01 (+1.61%)
Closing price 06/10/2025 04:00 PM Eastern
Extended Trading
$0.86 +0.02 (+1.79%)
As of 06/10/2025 06:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sutro Biopharma Short Interest Data

Sutro Biopharma (STRO) has a short interest of 6.86 million shares, representing 8.84% of the float (the number of shares available for trading by the public). This marks a 28.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.7, indicating that it would take 3.7 days of the average trading volume of 1.11 million shares to cover all short positions.

Current Short Interest
6,860,000 shares
Previous Short Interest
5,340,000 shares
Change Vs. Previous Month
+28.46%
Dollar Volume Sold Short
$6.03 million
Short Interest Ratio
3.7 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
84,461,000 shares
Short Percent of Float
8.84%
Today's Trading Volume
1,437,790 shares
Average Trading Volume
1,105,955 shares
Today's Volume Vs. Average
130%
Short Selling Sutro Biopharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sutro Biopharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

STRO Short Interest Over Time

STRO Days to Cover Over Time

STRO Percentage of Float Shorted Over Time

Sutro Biopharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20256,860,000 shares $6.03 million +28.5%8.8%3.7 $0.88
4/30/20255,340,000 shares $5.61 million -1.5%N/A2.9 $1.05
4/15/20255,420,000 shares $3.14 million +1.1%7.0%3.2 $0.58
3/31/20255,360,000 shares $3.49 million +15.5%6.9%3.8 $0.65
3/15/20254,640,000 shares $3.76 million +4.0%6.0%3.5 $0.81
2/28/20254,460,000 shares $7.09 million +1.1%5.7%4.2 $1.59
2/15/20254,410,000 shares $7.89 million +8.4%5.7%4.2 $1.79
1/31/20254,070,000 shares $7.81 million +5.7%N/A3.8 $1.92
1/15/20253,850,000 shares $7.05 million +22.2%N/A3.9 $1.83
12/31/20243,150,000 shares $5.80 million +28.1%N/A3.4 $1.84
12/15/20242,460,000 shares $5.22 million +19.4%N/A2.7 $2.12
11/30/20242,060,000 shares $5.46 million +15.1%N/A2.6 $2.65
11/15/20241,790,000 shares $5.17 million -25.4%N/A2.8 $2.89
10/31/20242,400,000 shares $7.80 million -16.1%N/A4 $3.25
10/15/20242,860,000 shares $10.95 million No ChangeN/A4.9 $3.83
9/30/20242,860,000 shares $9.90 million -4.4%N/A4.4 $3.46
9/15/20242,990,000 shares $13.46 million -1.0%N/A4 $4.50
8/31/20243,020,000 shares $13.80 million -10.9%N/A4.1 $4.57
8/15/20243,390,000 shares $13.70 million +6.3%N/A4.5 $4.04
7/31/20243,190,000 shares $12.66 million -13.8%N/A3.9 $3.97
7/15/20243,700,000 shares $15.61 million +14.6%N/A4.5 $4.22
6/30/20243,230,000 shares $9.46 million +41.1%N/A3.8 $2.93
6/15/20242,290,000 shares $7.92 million +20.5%N/A2.3 $3.46
5/31/20241,900,000 shares $8.03 million -2.6%N/A1.9 $4.23
5/15/20241,950,000 shares $7.66 million No ChangeN/A1.9 $3.93
4/30/20241,950,000 shares $6.62 million -10.6%N/A2 $3.40
4/15/20242,180,000 shares $9.03 million -9.5%N/A2.2 $4.14
3/31/20242,410,000 shares $13.62 million +3.9%N/A2.3 $5.65
3/15/20242,320,000 shares $9.54 million -3.7%N/A2.6 $4.11
2/29/20242,410,000 shares $11.83 million -9.7%N/A2.9 $4.91
2/15/20242,670,000 shares $11.99 million +2.3%N/A3.2 $4.49
1/31/20242,610,000 shares $11.33 million +8.8%N/A2.9 $4.34
1/15/20242,400,000 shares $9.60 million +1.7%N/A2.7 $4.00
12/31/20232,360,000 shares $10.12 million +24.2%N/A2.6 $4.29
12/15/20231,900,000 shares $7.56 million -8.2%N/A2.4 $3.98
11/30/20232,070,000 shares $5.40 million -10.0%N/A3 $2.61
11/15/20232,300,000 shares $5.66 million -3.0%N/A3.7 $2.46
10/31/20232,370,000 shares $6.52 million -4.4%N/A5.3 $2.75
10/15/20232,480,000 shares $9.77 million +5.1%N/A6.2 $3.94
9/30/20232,360,000 shares $8.19 million -2.5%N/A6.3 $3.47
Elon’s NEXT Big IPO? (Ad)

Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.

One that experts predict could be worth over $3.2 TRILLION globally by 2030.
9/15/20232,420,000 shares $9.46 million +28.7%N/A7.9 $3.91
8/31/20231,880,000 shares $8.93 million -2.1%N/A4.5 $4.75
8/15/20231,920,000 shares $8.20 million -1.5%N/A4.5 $4.27
7/31/20231,950,000 shares $8.72 million -1.5%N/A4.3 $4.47
7/15/20231,980,000 shares $9.37 million +2.1%N/A4 $4.73
6/30/20231,940,000 shares $9.02 million -36.8%N/A3.8 $4.65
6/15/20233,070,000 shares $16.61 million +2.0%N/A5.6 $5.41
5/31/20233,010,000 shares $13.51 million -2.9%N/A6.2 $4.49
5/15/20233,100,000 shares $18.23 million +4.4%N/A6.6 $5.88
4/30/20232,970,000 shares $12.65 million -2.3%N/A6.5 $4.26
4/15/20233,040,000 shares $13.38 million +8.6%N/A7.1 $4.40
3/31/20232,800,000 shares $12.94 million +77.2%N/A5.5 $4.62
3/15/20231,580,000 shares $8.53 million -16.0%N/A2.9 $5.40
2/28/20231,880,000 shares $10.60 million +0.5%N/A3.3 $5.64
2/15/20231,870,000 shares $11.61 million -3.6%N/A3.3 $6.21
1/31/20231,940,000 shares $14.05 million -8.1%N/A3.4 $7.24
1/15/20232,110,000 shares $16.61 million +8.2%N/A3.6 $7.87
12/30/20221,950,000 shares $15.76 million -22.9%N/A3.7 $8.08
12/15/20222,530,000 shares $18.60 million -4.2%N/A5.3 $7.35
11/30/20222,640,000 shares $19.77 million -30.7%N/A6.9 $7.49
11/15/20223,810,000 shares $27.93 million -8.2%N/A10.7 $7.33
10/31/20224,150,000 shares $30.42 million +0.2%9.2%12.6 $7.33
10/15/20224,140,000 shares $23.14 million +2.7%9.2%11.3 $5.59
9/30/20224,030,000 shares $22.37 million -5.0%8.9%11.3 $5.55
9/15/20224,240,000 shares $24.34 million -11.3%9.4%5.8 $5.74
8/31/20224,780,000 shares $27.05 million -7.9%10.8%5.8 $5.66
8/15/20225,190,000 shares $36.90 million +7.7%11.7%5.7 $7.11
7/31/20224,820,000 shares $28.20 million -1.0%12.1%5 $5.85
7/15/20224,870,000 shares $28.49 million -12.7%12.7%5 $5.85
6/30/20225,580,000 shares $29.07 million +22.1%14.6%5.8 $5.21
6/15/20224,570,000 shares $17.55 million +33.2%11.9%7.3 $3.84
5/31/20223,430,000 shares $14.92 million +7.9%9.0%6.1 $4.35
5/15/20223,180,000 shares $14.63 million +49.3%8.3%6.5 $4.60
4/30/20222,130,000 shares $12.80 million +17.0%5.9%4.5 $6.01
4/15/20221,820,000 shares $13.21 million +9.0%5.1%3.7 $7.26
3/31/20221,670,000 shares $13.73 million +31.5%4.7%3.3 $8.22
3/15/20221,270,000 shares $10.29 million -15.9%3.5%2.2 $8.10
2/28/20221,510,000 shares $13.47 million -0.7%4.2%2.8 $8.92
2/15/20221,520,000 shares $13.77 million -9.5%4.2%2.8 $9.06
1/31/20221,680,000 shares $17.94 million -17.2%4.6%3.2 $10.68
1/15/20222,030,000 shares $21.72 million -13.6%5.6%4.8 $10.70
12/31/20212,350,000 shares $34.97 million +3.1%N/A6.4 $14.88
12/15/20212,280,000 shares $35.23 million +34.9%6.3%9.4 $15.45
11/30/20211,690,000 shares $28.87 million +3.7%4.7%7.3 $17.08
11/15/20211,630,000 shares $31.21 million -14.2%4.5%7.7 $19.15
10/29/20211,900,000 shares $38.30 million -1.0%5.3%8.8 $20.16
10/15/20211,920,000 shares $36.46 million -9.0%5.3%8.1 $18.99
9/30/20212,110,000 shares $39.86 million -16.6%5.8%8.1 $18.89
9/15/20212,530,000 shares $50.57 million -10.3%7.0%8.2 $19.99
8/31/20212,820,000 shares $61.25 million -2.1%7.8%8.3 $21.72
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.

Now he's identified his next potential winner. Click here to find out more.
8/13/20212,880,000 shares $54.40 million -2.4%8.0%7.9 $18.89
7/30/20212,950,000 shares $50.24 million -0.3%8.1%7.3 $17.03
7/15/20212,960,000 shares $51.56 million -3.6%8.3%7.4 $17.42
6/30/20213,070,000 shares $57.07 million -9.4%8.6%7.4 $18.59
6/15/20213,390,000 shares $62.00 million -3.4%9.5%7.9 $18.29
5/28/20213,510,000 shares $65.32 million -4.9%9.9%7.4 $18.61
5/14/20213,690,000 shares $69.48 million No ChangeN/A7.5 $18.83
4/30/20213,690,000 shares $77.16 million No ChangeN/A7.7 $20.91
4/15/20213,690,000 shares $73.50 million +4.2%N/A7.1 $19.92
3/31/20213,540,000 shares $74.48 million +139.2%N/A6.4 $21.04
3/15/20211,480,000 shares $34.65 million +29.8%N/A2.6 $23.41
2/26/20211,140,000 shares $24.77 million +10.7%N/A1.8 $21.73
2/12/20211,030,000 shares $24.74 million +12.5%N/A1.6 $24.02
1/29/2021916,000 shares $20.43 million -19.7%N/A1.4 $22.30
1/15/20211,140,000 shares $29.56 million +1.8%N/A1.9 $25.93
12/31/20201,120,000 shares $24.45 million +85.3%N/A2.1 $21.83
12/15/2020604,400 shares $13.13 million -75.6%N/A1.2 $21.73
11/30/20202,480,000 shares $42.41 million -4.6%N/A5 $17.10
11/15/20202,600,000 shares $44.80 million -1.5%N/A6.9 $17.23
10/30/20202,640,000 shares $34.87 million -0.8%N/A6.8 $13.21
10/15/20202,660,000 shares $32.53 million -0.8%N/A7.8 $12.23
9/30/20202,680,000 shares $26.93 million +100.0%N/A7.9 $10.05
9/15/20201,340,000 shares $14.94 million +78.1%N/A3.9 $11.15
8/31/2020752,300 shares $7.53 million +3.9%3.3%2.6 $10.01
8/14/2020724,100 shares $6.15 million -5.6%3.2%3.9 $8.49
7/31/2020767,300 shares $5.96 million -3.3%N/A4.6 $7.77
7/15/2020793,500 shares $6.94 million +11.5%3.5%4.9 $8.74
6/30/2020711,600 shares $5.60 million +450.8%3.1%4.8 $7.87
6/15/2020129,200 shares $1.15 million +101.6%0.6%1.2 $8.88

STRO Short Interest - Frequently Asked Questions

What is Sutro Biopharma's current short interest?

Short interest is the volume of Sutro Biopharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 6,860,000 shares of STRO short. 8.84% of Sutro Biopharma's shares are currently sold short. Learn More on Sutro Biopharma's current short interest.

What is a good short interest ratio for Sutro Biopharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. STRO shares currently have a short interest ratio of 4.0. Learn More on Sutro Biopharma's short interest ratio.

What is a good short interest percentage for Sutro Biopharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.84% of Sutro Biopharma's floating shares are currently sold short.

Is Sutro Biopharma's short interest increasing or decreasing?

Sutro Biopharma saw a increase in short interest in May. As of May 15th, there was short interest totaling 6,860,000 shares, an increase of 28.5% from the previous total of 5,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Sutro Biopharma's short interest compare to its competitors?

8.84% of Sutro Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sutro Biopharma: Olema Pharmaceuticals, Inc. (12.78%), Compass Therapeutics, Inc. (7.86%), Rocket Pharmaceuticals, Inc. (21.39%), Heron Therapeutics, Inc. (24.01%), Aurora Cannabis Inc. (9.38%), Terns Pharmaceuticals, Inc. (8.22%), Cidara Therapeutics, Inc. (5.80%), Candel Therapeutics, Inc. (17.07%), Aquestive Therapeutics, Inc. (11.71%), Tonix Pharmaceuticals Holding Corp. (12.41%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Sutro Biopharma stock?

Short selling STRO is an investing strategy that aims to generate trading profit from Sutro Biopharma as its price is falling. STRO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sutro Biopharma?

A short squeeze for Sutro Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of STRO, which in turn drives the price of the stock up even further.

How often is Sutro Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STRO, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:STRO) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners